Scientists test custom cancer vaccine on advanced melanoma patients
NCT ID NCT00626860
Summary
This early-stage study tested a personalized vaccine made by combining a patient's own cancer cells with immune cells. The goal was to see if this approach was safe and could train the immune system to attack advanced melanoma. The trial involved 20 patients with spreading melanoma to check for side effects and immune responses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BIDMC
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.